EligibleTrials

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Recruiting · NCT06122077 · Observational (researchers observe without assigning treatment) · Lead sponsor: Freenome Holdings Inc.

View the official record on ClinicalTrials.gov →
Lung cancerCOPD

Interventions studied

blood draw

What this trial is about

The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from high-risk participants who will undergo a routine, standard-of-care screening Low-Dose Computed Tomography (LDCT).

Who can take part

Age range
50 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

36 locations listed across 22 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.